Fluid Biomed aims to make its polymer-based stent the next generation in the approach to vascular disease treatment.

Calgary-based medical device startup Fluid Biomed has secured $27 million USD in Series A funding to fuel the development of ...

Unlike traditional metal stents, the flow-diverting stent naturally absorbs into the body once healing is complete, meaning patients will potentially be saved from a lifetime regimen of blood ...

Fluid Biomed has raised $27 million to move forward with the development of its bioabsorbable stent designed to divert blood ...